Practices


Merck withdraws Vioxx

September 30, 2004 - Merck & Co. faces a rocky future after withdrawing its blockbuster arthritis pain drug Vioxx, a high-margin product that had accounted for almost 20% of its profit. Read More


Merck withdraws Arthritis Drug Vioxx

September 30, 2004 - Merck & Co. withdrew its arthritis drug Vioxx globally after a colon cancer trial confirmed long-standing concerns the drug raises the risk of heart attack and stroke. Read More


Vioxx linked to Increased Risk of Heart Attacks

September 2, 2004 - Taking more than 25 mg per day of Vioxx is linked to a tripling of the risk of heart attack, said a paper presented in the International Society for Pharmacoepidemiology Conference in... Read More


Vioxx Increases risk of Heart Attack Three Times

September 2, 2004 - Patients taking the popular arthritis drug Vioxx have three times the risk of heart attack as people not taking the medication, new research suggests. Read More


Serzone lawsuit filed against Bristol-Myers Squibb

August 31, 2004 - A lawsuit was filed Monday in the Supreme Court of the State of New York on behalf on plaintiff Harry E. French, Jr., who alleges he developed Serzone-induced hepatitis on or about... Read More


FDA finds link between Vioxx and Heart Problems

August 26, 2004 - One of the nation's biggest HMO's may be reconsidering it's endorsement of the popular prescription medication, Vioxx, after a new study found some potentially disturbing data. Read More


Drugmaker sued in Serzone-related death

May 18, 2004 - Bristol-Myers Squibb Co. was sued by the family of a woman who claims that the company's Serzone antidepressant caused her death. Cassie Jo Geisenhof, 19, was prescribed Serzone for... Read More


Her Body Burned by Drug, not Fire

May 4, 2004 - A beautiful 18-year-old Tucson softball player has suffered severe burns over 80 percent of her body but has been nowhere near a fire. Read More


Teen Death Stirs Fresh Debate About Depression Medication

April 20, 2004 - The death of a teenager last week from liver failure is raising questions anew about an antidepressant that continues to be available in the U.S. despite having been removed from the market... Read More


Australia Places Strict Label Warnings on COX-2 Inhibitors

February 15, 2004 - Just days before a Food and Drug Administration advisory committee meets to discuss the future of Celebrex, Bextra and related arthritis drugs, the agency's Australian counterpart has... Read More


back to top